145 related articles for article (PubMed ID: 22834292)
1. [Methods of heparin therapy in surgical patients with thrombohemorrhagic syndrome].
Gasanov FD
Anesteziol Reanimatol; 2012; (2):61-4. PubMed ID: 22834292
[TBL] [Abstract][Full Text] [Related]
2. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
Kakkar VV; Howes J; Sharma V; Kadziola Z
Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
[TBL] [Abstract][Full Text] [Related]
3. [Assessment of complications of major orthopedic surgery: comparison of indobufen, calcium heparin, and low molecular heparin].
Borghi B; Bassi A; Grazia M; Feoli MA; Pignotti E
Minerva Anestesiol; 1996 Mar; 62(3):93-100. PubMed ID: 8767154
[TBL] [Abstract][Full Text] [Related]
4. Comparison of low molecular weight heparin with unfractionated heparin during percutaneous coronary interventions: a meta-analysis.
Kodumuri V; Adigopula S; Singh P; Swaminathan P; Arora R; Khosla S
Am J Ther; 2011 May; 18(3):180-9. PubMed ID: 20027109
[TBL] [Abstract][Full Text] [Related]
5. [Comparative study of 2 antithrombotic regimens in 75 patients with coronary endoprostheses].
Iturbe T; Sánchez C; Moreno JA; Olave T; Azaceta G; Varo MJ; Civeira E; Peleato J; Cornudella R
Sangre (Barc); 1997 Oct; 42(5):387-90. PubMed ID: 9424739
[TBL] [Abstract][Full Text] [Related]
6. [Blood coagulation changes in lung surgery and their prevention by heparin].
Ruseĭkin NS; Gur'ianov VN
Grudn Khir; 1989; (4):47-50. PubMed ID: 2792878
[TBL] [Abstract][Full Text] [Related]
7. [Heparin prophylaxis of thrombohemorrhagic complications in surgical interventions in cancer patients].
Nadiradze ISh
Vopr Onkol; 1989; 35(8):974-9. PubMed ID: 2800447
[TBL] [Abstract][Full Text] [Related]
8. [Prophylaxis of postoperative thromboembolism. Randomized prospective study].
Manso LC; Milheiro A; Castro e Sousa F
Acta Med Port; 1996; 9(2-3):87-90. PubMed ID: 8967308
[TBL] [Abstract][Full Text] [Related]
9. [Complex prevention of thrombotic complications in patients with colorectal cancer during different stages of surgical treatment].
Mal'kov OA; Dolgikh VT; Lukach VN
Anesteziol Reanimatol; 2001; (5):52-4. PubMed ID: 11757303
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of lower-dose unfractionated heparin for prophylaxis of deep vein thrombosis and pulmonary embolism in an Asian population.
Ugaki H; Enomoto T; Fujiwara K; Kimura T; Kawasaki T
Blood Coagul Fibrinolysis; 2008 Sep; 19(6):585-9. PubMed ID: 18685443
[TBL] [Abstract][Full Text] [Related]
11. Angiographic and clinical outcomes in patients receiving low-molecular-weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 Trial.
Sabatine MS; Morrow DA; Montalescot G; Dellborg M; Leiva-Pons JL; Keltai M; Murphy SA; McCabe CH; Gibson CM; Cannon CP; Antman EM; Braunwald E;
Circulation; 2005 Dec; 112(25):3846-54. PubMed ID: 16291601
[TBL] [Abstract][Full Text] [Related]
12. [Comparison between low-molecular and unfractionated heparin in the prevention of thrombosis in patients with total endoprosthetic replacement of hip and knee joint].
Rader CP; Kramer C; König A; Gohlke F; Eulert J
Z Orthop Ihre Grenzgeb; 1997; 135(1):52-7. PubMed ID: 9199074
[TBL] [Abstract][Full Text] [Related]
13. Management of thrombosis during pregnancy.
Inbal A
Isr Med Assoc J; 2002 Oct; 4(10):813-4. PubMed ID: 12389348
[No Abstract] [Full Text] [Related]
14. [Indications and clinical application of thrombosis prophylaxis. I].
Mittelkötter U; Reith HB; Thiede A
Zentralbl Chir; 2000; 125(7):W49-52. PubMed ID: 10960979
[No Abstract] [Full Text] [Related]
15. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
Míka P; Behounek J; Skoták M; Nevsímal L
Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the effectiveness and safety of low-molecular weight heparin versus unfractionated heparin anticoagulation after heart valve surgery.
Bucci C; Geerts WH; Sinclair A; Fremes SE
Am J Cardiol; 2011 Feb; 107(4):591-4. PubMed ID: 21184996
[TBL] [Abstract][Full Text] [Related]
17. [Recommendations for peri-procedural thrombocyte aggregation inhibition].
Sauer H; Leschke M
Dtsch Med Wochenschr; 2006 Feb; 131(8):400-2. PubMed ID: 16479474
[No Abstract] [Full Text] [Related]
18. [The effect of Clexane (low-molecular-weight heparin) on the hemostatic system and on the incidence of postoperative thrombotic complications in gynecological cancer patients].
Madzhuga AV; Somonova OV; Kononenko LP; Gorobets ES; Elizarova AL; Astakhova VM
Anesteziol Reanimatol; 2000; (2):54-6. PubMed ID: 10833839
[TBL] [Abstract][Full Text] [Related]
19. Out of hospital antithrombotic prophylaxis after total hip replacement: low-molecular-weight heparin, warfarin, aspirin or nothing? A cost-effectiveness analysis.
Sarasin FP; Bounameaux H
Thromb Haemost; 2002 Apr; 87(4):586-92. PubMed ID: 12008939
[TBL] [Abstract][Full Text] [Related]
20. Comparison of six-month outcome of patients initially treated for acute deep vein thrombosis with a low molecular weight heparin Certoparin at a fixed, body-weight-independent dosage or unfractionated heparin.
Harenberg J; Riess H; Büller HR; Brom J; Weidinger G; Huisman MV
Haematologica; 2003 Oct; 88(10):1157-62. PubMed ID: 14555312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
